Hermetica Superfood Encyclopedia
The Short Answer
Buddleja saligna leaves and stems contain high-density polyphenols, flavonoids, proanthocyanidins, and triterpenoids that act as free radical scavengers and COX-2 inhibitors, while also suppressing pro-inflammatory cytokines IL-6 and IL-8. Its triterpenoid fraction demonstrates the most potent documented activity, achieving an antiproliferative IC50 of 5.45 ± 0.19 µg/mL against UCT-MEL-1 melanoma cells with a selectivity index of 5.06 relative to normal keratinocytes.
CategoryHerb
GroupAfrican
Evidence LevelPreliminary
Primary KeywordTsangariorio benefits
Tsangariorio — botanical close-up
Health Benefits
**Antioxidant Protection**: Methanol extracts of B
saligna leaves and stems achieve DPPH inhibition of 93.8–94.9% and ABTS inhibition of 98.8–100% at 0.1 mg/mL, driven by polyphenol content of 15.65 mg/g (leaves) and 25.31 mg/g (stems), suggesting potent free radical neutralization capacity.
**Anti-Inflammatory Activity**: Crude extracts inhibit COX-2 with an IC50 of 35
06 ± 2.96 µg/mL, while the isolated triterpenoid fraction achieves 26.40 ± 4.19 µg/mL; at 30 µg/mL, IL-6 is suppressed by 83.26% and IL-8 by 100%, pointing to meaningful cytokine pathway modulation.
**Antiproliferative / Anticancer Potential**
The triterpenoid-enriched fraction (DT-BS-01) exhibits selective cytotoxicity against UCT-MEL-1 melanoma cells (IC50 5.45 µg/mL, selectivity index 5.06 vs. keratinocytes), indicating preferential targeting of malignant over normal cells in vitro.
**Antibacterial Broad-Spectrum Activity**
Extracts display inhibitory activity against ten bacterial strains, including five Gram-positive and five Gram-negative species, though minimum inhibitory concentrations remain higher than reference antibiotics chloramphenicol and streptomycin.
**Traditional Respiratory Support**
Within South African ethnomedicine, the whole plant is prepared and administered for the treatment of colds and upper respiratory complaints, consistent with its documented antimicrobial and anti-inflammatory phytochemical profile.
**Digestive and Purgative Use**: B
saligna has documented traditional use as a purgative in indigenous South African practice, suggesting bioactive constituents capable of stimulating gastrointestinal motility, though no pharmacological mechanism has been formally characterized.
**Ophthalmic Applications (Traditional)**
The plant is used in traditional African medicine specifically for the treatment of eye problems, a use that may relate to its antioxidant and anti-inflammatory properties, though no clinical or mechanistic ocular studies have been conducted.
Origin & History
Natural habitat
Buddleja saligna is indigenous to southern Africa, particularly South Africa, where it grows across a range of habitats including riverbanks, rocky slopes, and woodland margins at varying altitudes. It is a fast-growing evergreen shrub or small tree adapted to well-drained soils and moderate rainfall zones, and is widely distributed across the Cape Floristic Region and into subtropical highland areas. The plant has not been subject to formal commercial cultivation; its use remains rooted in wild harvesting by indigenous communities practicing traditional South African medicine.
“Buddleja saligna occupies a recognized place in South African indigenous medicine, where it is used by various communities across the country for treating colds, eye disorders, and gastrointestinal complaints including the use as a purgative. The broader genus Buddleja has extensive ethnopharmacological documentation across southern Africa and South America, with Mapuche communities in Chile employing the related species B. globosa for wound healing and liver ailments, reflecting a pan-hemispheric pattern of genus-level medicinal application. In South Africa, the plant's common name Tsangariorio reflects its use within specific linguistic and cultural communities, though detailed records of ritualistic or ceremonial application are not well-documented in the academic literature. The alignment between its traditional uses and modern in vitro findings in anti-inflammation and antimicrobial activity lends ethnopharmacological plausibility to its historical reputation, even in the absence of formal clinical validation.”Traditional Medicine
Scientific Research
All available evidence for B. saligna derives exclusively from in vitro laboratory studies; no human clinical trials, animal pharmacokinetic studies, or randomized controlled trials have been published. Two primary studies characterize the bulk of available data: one investigating antioxidant and antibacterial activity of methanol extracts from leaves and stems, and one examining antiproliferative and anti-inflammatory effects of crude and fractionated triterpenoid extracts against melanoma cell lines and COX-2 enzyme assays. Phytochemical profiling has identified 22 compounds across growth stages of the plant, though individual compound identities and quantified abundances remain incompletely documented in the accessible literature. The evidence base is therefore preliminary and preclinical, and no conclusions regarding human efficacy, optimal dose, or therapeutic index can be drawn from existing data.
Preparation & Dosage
Traditional preparation
**Traditional Whole-Plant Decoction**
Historically prepared from the whole plant (leaves, stems, bark) by boiling in water for use in treating colds, eye complaints, and as a purgative; no standardized volume or concentration is documented.
**Methanol/Ethanol Leaf Extract (Research Use Only)**
In vitro studies used concentrations of 0.1–160 µg/mL; these solvent-based extracts are not suitable for human consumption and do not correspond to any safe or practical supplemental dose.
**Triterpenoid Fraction (DT-BS-01, Research Use Only)**
Dichloromethane partitioning of ethanolic extracts yields a triterpenoid-enriched fraction active at IC50 5.45 µg/mL in cell assays; no human-equivalent dose has been established.
**Standardized Supplement Forms**
No commercially available capsules, tablets, tinctures, or standardized extracts of B. saligna exist as of current literature; no standardization percentages for polyphenols or triterpenoids are defined for commercial use.
**Dosage Guidance**
No evidence-based dosage recommendation can be made; any preparation for internal use should be approached with caution given the absence of human safety and pharmacokinetic data.
Nutritional Profile
Buddleja saligna is not consumed as a food source, and conventional macronutrient or micronutrient profiling data are absent from the literature. Phytochemically, the leaves contain total polyphenols at 15.65 ± 0.21 mg/g dry weight, flavonoids at 1.61 ± 0.01 mg/g, total flavonols at 0.76 ± 0.05 mg/g, and proanthocyanidins at 1.67 ± 1.01 mg/g. Stems are richer in polyphenols (25.31 ± 1.37 mg/g) and proanthocyanidins (4.80 ± 0.35 mg/g), while containing lower flavonoids (0.83 mg/g) and flavonols (0.10 mg/g). A total of 22 secondary metabolites including triterpenoids have been identified across plant growth stages, but individual compound identities, concentrations, and oral bioavailability data remain undetermined.
How It Works
Mechanism of Action
Phenolic compounds and flavonoids in B. saligna act as electron donors and hydrogen atom transfer agents, quenching reactive oxygen species as measured by DPPH, ABTS, and FRAP assays, with stems showing particularly high ferric-reducing capacity of 1546.98 ± 63.67 µmol Fe(II)/g. The triterpenoid fraction inhibits cyclooxygenase-2 (COX-2) at the enzymatic level, reducing prostaglandin biosynthesis, while simultaneously suppressing transcription or secretion of IL-6 and IL-8, implicating potential NF-κB or MAPK pathway interference. Antiproliferative effects against melanoma cells are attributed to the triterpenoid mixture DT-BS-01, which may disrupt cell cycle progression or induce apoptosis via mitochondrial pathways, consistent with mechanisms reported for related pentacyclic triterpenoids in the literature. Antibacterial activity is consistent with membrane disruption or enzyme inhibition by polyphenolic and flavonoid components, though the precise bacterial molecular targets have not been characterized for this species.
Clinical Evidence
No clinical trials in human subjects have been conducted on Buddleja saligna or its extracts in any formulation. The entirety of quantified outcome data originates from cell-based assays and enzyme inhibition experiments conducted in vitro, using methanol, ethanol, or dichloromethane extract concentrations ranging from 0.1 to 160 µg/mL. While antiproliferative IC50 values and cytokine inhibition percentages provide biologically meaningful signals, these cannot be directly extrapolated to human therapeutic doses, bioavailability, or clinical effect sizes. Confidence in clinical applicability remains very low, and B. saligna should be regarded as a candidate for further preclinical and eventual clinical investigation rather than an evidence-supported therapeutic intervention.
Safety & Interactions
No formal human safety studies, toxicology reports, or adverse event data exist for Buddleja saligna or any of its extracts, and no maximum tolerated dose or no-observed-adverse-effect level has been established in any species. In vitro selectivity indices of 1.52 to 5.06 comparing cytotoxicity in melanoma cells versus normal keratinocytes suggest differential but not absolute selectivity, offering limited reassurance about systemic safety. No drug interaction data are available; however, given the plant's COX-2 inhibitory and antioxidant mechanisms, theoretical interactions with NSAIDs, anticoagulants, and immunosuppressants cannot be excluded. Use during pregnancy or lactation is not recommended given the plant's traditional purgative application and the complete absence of reproductive safety data.
Synergy Stack
Hermetica Formulation Heuristic
Also Known As
Buddleja salignaTsangariorioFalse OliveWillow BuddlejaUmdlebe
Frequently Asked Questions
What is Tsangariorio used for in traditional African medicine?
Tsangariorio (Buddleja saligna) is used in South African indigenous medicine primarily for treating eye problems, relieving cold symptoms, and as a purgative for gastrointestinal complaints. The whole plant is typically prepared as a decoction, and its traditional applications align broadly with the anti-inflammatory and antimicrobial properties identified in modern in vitro studies, though no clinical trials have confirmed these uses in humans.
Does Buddleja saligna have scientifically proven health benefits?
Buddleja saligna has demonstrated antioxidant, anti-inflammatory, antibacterial, and antiproliferative effects exclusively in laboratory (in vitro) studies. Key findings include 93.8–94.9% DPPH free radical inhibition and a COX-2 IC50 of 35.06 µg/mL for crude extracts; however, no human clinical trials have been conducted, so proven clinical health benefits in people cannot be established at this time.
What are the active compounds in Buddleja saligna?
The primary bioactive compounds in Buddleja saligna include polyphenols (up to 25.31 mg/g in stems), flavonoids, flavonols, proanthocyanidins, and a triterpenoid mixture designated DT-BS-01. The triterpenoid fraction is particularly notable for its selective antiproliferative activity against melanoma cells (IC50 5.45 µg/mL) and its superior COX-2 inhibitory potency compared to the crude extract.
Is Tsangariorio safe to take as a supplement?
No formal human safety data, toxicology studies, or established safe dosage ranges exist for Tsangariorio or any Buddleja saligna extract. While traditional use implies general tolerability, its documented purgative effects and the absence of pharmacokinetic or reproductive safety data mean it should not be used as a dietary supplement without medical supervision, particularly during pregnancy or alongside medications such as NSAIDs or anticoagulants.
What is the recommended dose of Buddleja saligna extract?
No evidence-based recommended dose exists for Buddleja saligna in any form. Research studies used in vitro concentrations of 0.1–160 µg/mL in solvent-based extracts, which are not appropriate for extrapolating to human oral doses. No commercially standardized supplements are currently available, and any therapeutic use should await the results of pharmacokinetic and clinical dose-ranging studies.
How does Buddleja saligna compare to other antioxidant herbs in terms of free radical neutralization?
Buddleja saligna demonstrates exceptional antioxidant capacity with DPPH inhibition of 93.8–94.9% and ABTS inhibition of 98.8–100% at 0.1 mg/mL, placing it among the most potent botanical antioxidants tested. This superior performance is attributed to its high polyphenol content (15.65 mg/g in leaves and 25.31 mg/g in stems), which rivals or exceeds many commonly used antioxidant supplements like green tea extract and turmeric. The stem extract shows particularly strong antioxidant potential due to higher polyphenol concentration compared to the leaves.
Which part of Buddleja saligna—leaves or stems—is more potent for supplementation?
The stems of Buddleja saligna are more potent than the leaves, containing significantly higher polyphenol content at 25.31 mg/g compared to 15.65 mg/g in leaves. While both parts demonstrate strong antioxidant and anti-inflammatory activity, stem extracts achieve superior free radical neutralization capacity due to their elevated polyphenol concentration. This makes stem-based extracts the preferred choice for maximizing bioactive compound delivery in supplement formulations.
What does the COX-2 inhibition data suggest about Buddleja saligna's anti-inflammatory mechanism?
Buddleja saligna's crude extract inhibits COX-2 with an IC50 of 35.06 ± 2.96 µg/mL, indicating it works through the cyclooxygenase pathway—the same mechanism targeted by nonsteroidal anti-inflammatory drugs (NSAIDs). This COX-2 selective activity suggests the herb may help modulate inflammatory responses without the systemic effects of pharmaceutical inhibitors. The combination of polyphenol-driven antioxidant action with COX-2 inhibition provides a multi-pathway approach to reducing inflammation.
Explore the Full Encyclopedia
7,400+ ingredients researched, verified, and formulated for optimal synergy.
Browse IngredientsThese statements have not been evaluated by the Food and Drug Administration. This content is for informational purposes only and is not intended to diagnose, treat, cure, or prevent any disease.
hermetica-encyclopedia-canary-zzqv9k4w tsangariorio-buddleja-saligna curated by Hermetica Superfoods at ingredients.hermeticasuperfoods.com and licensed CC BY-NC-SA 4.0 (non-commercial share-alike, attribution required)
